By Davit Kirakosyan
Raymond James reinstated coverage on Duolingo Inc (NASDAQ:) with an Outperform rating and a price target of $111 ahead of the Q3 earnings announcement on Thursday. The analysts maintain their positive view on the company’s shares, expecting an upside to Q3 MAUs (monthly active users).
Raymond James initiated coverage on Kymera Therapeutics Inc (NASDAQ:) with a Market Perform rating. Shares rose more than 4% today.
Canaccord Genuity initiated coverage on Taysha Gene Therapies Inc (NASDAQ:) with a Buy rating. Shares gained 10% today following the company’s reported .
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
Story Credit: investing.com